The anti-MERS-CoV activities of three medicinal plants (Azadirachta indica, Artemisia
judaica, and Sophora tomentosa) were evaluated. The highest viral inhibition percentage …

SARS-CoV-2 (severe acute respiratory distress syndrome coronavirus 2) is the causative
agent for the novel coronavirus disease 2019 (COVID-19). It raises serious biosecurity …

In this study, an integrated in silico–in vitro approach was employed to discover natural
products (NPs) active against SARS-CoV-2. The two SARS-CoV-2 viral proteases, ie, main …

The COVID-19 pandemic has spread throughout the whole globe, so it is imperative that all
available resources be used to treat this scourge. In reality, the development of new …

The COVID-19 pandemic has led to the search for new molecules with antiviral activity
against SARS-CoV-2. The entry of the virus into the cell is one of the main targets for …

Novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was first
identified in China in December 2019. Currently, the novel coronavirus disease 2019 …

Objective: The high transmission rate and mutations of SARS-CoV-2 have made it a global
pandemic, and the shortage of any effective clinical treatment has created such a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) main protease (S-CoV-2
Mpro) is one of the main targets in designing antiviral against SARS-CoV-2. Centella …

Abstract Coronavirus 3C-like protease (3CL pro) is a crucial target for treating coronavirus
diseases including COVID-19. Our preliminary screening showed that Ampelopsis …